TXMD - TherapeuticsMD Inc Market Cap to Sales Volume

Corporate company logo of TherapeuticsMD Corp (TXMD)

TherapeuticsMD, Inc. (TXMD) is a recognized expert in hormonal imbalance therapy trusted by physicians. The change in the price-to-sales ratio visualizes the market valuation of assets, with the value stabilizing at 5.70. Streamlined supply chains to pharmacy networks ensure stable revenue. Currently, the primary threats have shifted toward a potential decrease in licensing payments from partners.

TXMD: TherapeuticsMD, Inc. P/S Multiple 07/04/2022 - 11/15/2026

Analytical breakdowns for therapeuticsmd.com (TXMD)

- stock price and consensus target price:
Share Price TherapeuticsMD Corp|TXMD - Consensus Target
- market capitalization statistics:
Market Value TXMD|TXMD - Enterprise Value
- book capitalization information:
Accounting Value of a Share TherapeuticsMD|TXMD - Book Capitalization|Market-to-Book Ratio therapeuticsmd.com|TXMD - Aggregate Company Assets
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio TherapeuticsMD, Inc.|TXMD - Long-Term Debt to Capital|Short-Term Debt to Capital TherapeuticsMD Inc|TXMD - Company Debts|Debts to Book Capitalization Ratio TXMD|TXMD - Company Long-Term Debts|Short-Term Debt TherapeuticsMD|Quick Ratio therapeuticsmd.com
- earnings and valuation multiples information:
TXMD - Net Income|Future Net Profit TherapeuticsMD, Inc.|TXMD - P/E Multiple|Market Cap to Projected Earnings TherapeuticsMD|TXMD - PEG Multiple|Enterprise Value to EBITDA Ratio TherapeuticsMD|TXMD - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters TherapeuticsMD|TXMD - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months therapeuticsmd.com|TXMD - Earnings growth in current year|Projected earnings per share growth rate for next year TherapeuticsMD, Inc.
- issuer revenue and sales details:
TXMD - Company Sales|Company Future Revenue TherapeuticsMD|TXMD - P/S Multiple|Market Cap to Expected Sales Ratio TherapeuticsMD
Fundamental company analysis:TherapeuticsMD Corp - TXMD
Finished products of TherapeuticsMD, Inc.

The P/S multiple relates market capitalization to annual sales volume, determining the cost of one dollar of revenue. This calculation allows an investor to filter out emotional price noise and assess the actual degree of capital protection. By analyzing the price-to-sales ratio, one can identify the gap between fundamental value and market expectations. For TherapeuticsMD, Inc. (TXMD), the transition to licensing women's health products should optimize costs and activate operating leverage.

Competing companies

OGN - Price to Sales|P/S Multiple DARE (Dare Bioscience, Inc.)|P/S Multiple Palatin Corp PTN